# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
- Reuters Citing Moody's Ratings
The gravity-defying climb faces risk, as the index futures trade narrowly mixed in early trading on Tuesday. That said, the rec...
TD Cowen analyst Yaron Weber maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $360 to $381.
Amgen posted mixed Q2 results. Analysts highlight upcoming clinical readouts in obesity and inflammatory disease as crucial. De...
Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and maintains $380 price target.